Subscribe to Search results

John Petricciani sent a memo to all licensed manufacturers of plasma derivatives on behalf of the FDA and Department of Human and Health Services, setting out an appropriate approach by which to decrease the potential risk of transmitting AIDS by plasma derivatives.

Published on:

Lee Stay was investigated at Lord Mayor Treloar Hospital and College, where Dr Anthony Aronstam was the lead clinician, for signs of AIDS.

Published on:

Lee Stay had three different commercial concentrates as well as some NHS product when attending Treloar's.

Published on:

Testing was a general pattern at Treloar's.

Published on:

The Lancet published an article by Professor Ludlam and others on "Disorder Immune Regulation in Haemophiliacs not Exposed to Commercial Factor VIII".

Published on:

An article titled "Immunological Abnormalities in Haemophilia - Are They Caused by American Factor VIII Concentrate?" by Froebel et al was published in the British Medical Journal, which argued against a disease vector specific to American blood products.

Published on:

An article titled "AIDS surveillance in haemophilia" by Daly et al was published in the British Journal of Haematology.

Published on:

Dr Robert Gallo's team in the US identified the Cytopathic Retroviruses virus as the presumptive cause of AIDS and named it HTLV-3.

Published on:

Dr Lane described the response to the syndrome as "the American over-reaction to the problem" and that the causative factors remained unknown. He suggested an urgent meeting to discuss strategic alternatives at BPL for manufacturing small pool freeze-dried cryoprecipitate, in anticipation of increased resistance to American products.

Published on:

The Central Blood Laboratories Authority met to primarily discuss budget and stockpiling. Professor Bloom suggested the Authority should discuss AIDS at a future meeting.

Published on:

Dr Lane, of BPL, prepared a progress report on AIDS regarding BPL's response to the possible impact of AIDS, namely a "wait and see" basis production policy for the manufacture of Factor 8 and research and development programmes in light of the AIDS concern in the USA.

Published on:

The CDC published an "Update on Acquired Immune Deficiency Syndrome (AIDS) - United States" article in their Morbidity and Mortality Weekly Report, reporting 593 received reports of AIDS between June 1981 and September 1982.

Published on:

Dr Anne Smith, of the Scottish Blood Transfusion Service, received a letter from Hunter Burns & Ogg (solicitors) in relation to the Scottish AIDS Monitor (SAM) to ensure the accurate recording on AIDS and to publish bulletins within the gay community.

Published on:

The Public Health Laboratory Service Communicable Disease Surveillance Centre prepared an article published in the British Medical Journal titled "Surveillance of the acquired immune deficiency syndrome in the United Kingdom, January 1982 - July 1983".

Published on:

The film, Killer in the Village, aired on BBC2, which traced the spread of AIDS across America, and followed the search for a cause and cure, and examined whether the seeds of a spreading epidemic had already reached London.

Published on:

The Central Blood Laboratories Authority held a meeting. Professor Bloom reported that he had given a talk on AIDS to the AGM of the Haemophilia Society, and got the impression that people with haemophilia were not greatly concerned about AIDS.

Published on:

Professor Anthony John Pinching prepared a written statement for the Infected Blood Inquiry on the advent of the risk of AIDS in the 1980s.

Published on:

The Guardian reported that two haemophilia patients had contracted AIDS and bans on the import of US blood products were being considered after reports that AIDS was being spread through infected blood.

Published on:

The Daily Mail referred to AIDS as killer homosexual disease and the Daily Express called it the new killer disease.

Published on:

The Lancet reported that no definite cases of AIDS had been reported in a person with haemophilia in the UK, however one patient might have had early features of the syndrome.

Published on: